{
}
Barclays analyst Saket Kalia has reduced nCino Inc.'s price target from $44 to $24 while maintaining an Overweight rating, citing a significant cut in the company's previous target. Despite a 13% revenue growth over the past year, nCino's fiscal 2026 outlook remains cautious due to challenges in the U.S. mortgage market. The company reported mixed Q4 2025 earnings, missing EPS forecasts but slightly exceeding revenue expectations, while CEO Sean Desmond announced a strategic shift towards AI banking solutions.
Roper Technologies, Inc. has a market cap of $62.57 billion and recently announced a quarterly dividend of $0.825 per share, with a yield of 0.57%. Insider trading activity includes CFO Jason Conley selling 3,000 shares, reducing his ownership by 8.69%. Analysts maintain a "Moderate Buy" rating, with price targets ranging from $558 to $685.
Barclays has downgraded Canada Goose's stock rating from Equal Weight to Underweight, lowering the price target from $10 to $8 amid concerns over global macroeconomic pressures, increasing competition, and tariff risks. The stock, currently at $8.24, has dropped over 34% in six months and is near its 52-week low. Despite a recent earnings beat, revenue fell short of expectations, prompting analysts to express caution about the company's future performance.
JPMorgan Chase & Co. raised its target price on Raymond James from $166 to $172, maintaining a "neutral" rating, while JMP Securities increased its target from $175 to $190 with a "market outperform" rating. Analysts show a consensus "Hold" rating with an average price target of $167.55. Raymond James reported a quarterly EPS of $2.93, exceeding estimates, and announced a dividend of $0.50 per share, payable on April 15.
BNP Paribas Financial Markets increased its stake in HealthEquity by 165.7% in Q3, now holding 20,437 shares valued at $1.67 million. Charles Schwab Investment Management also raised its position by 2.4% in Q4, owning over 1 million shares worth $104.28 million. Institutional investors control 99.55% of the stock, which has a current average rating of "Buy" and a consensus target price of $112.23.
UBS has maintained a Buy rating on Dollar Tree stock with a price target of $95, citing the recent divestiture of its Family Dollar business as a key move to enhance shareholder value. This strategic shift is expected to improve cash flow and earnings, while the company is poised to benefit from consumer trade-down trends, projecting comparable store sales growth of 3-5% in 2025. Despite potential risks from tariffs and competition, analysts remain optimistic about Dollar Tree's financial growth and operational improvements.
Morgan Stanley has initiated coverage on Tenet Healthcare with an Overweight rating and a price target of $165, citing the company's strategic positioning in outpatient services and effective management of its acute care business. Despite a 22% stock decline since the election, analysts remain optimistic about Tenet's growth potential, bolstered by significant debt reduction and improved liquidity. Fitch Ratings upgraded Tenet's Issuer Default Rating to 'BB-', reflecting its enhanced competitive position and anticipated EBITDA growth.
Truist Securities has enhanced its biotech equity research team with the addition of Danielle Brill, who brings extensive experience from her previous roles at Raymond James and other firms. Brill's insights will support the firm's institutional clients in navigating the evolving biotech landscape, alongside a growing team of experts in various sectors. The firm aims to leverage new technologies and high-touch service to deliver differentiated, data-driven content to its clients.
Truist Financial has seen several analysts adjust their target prices, with Barclays and Raymond James both raising theirs to $51, while Goldman Sachs increased it to $60. The company currently holds a "Moderate Buy" rating, with an average target price of $50.79. Institutional investors own 71.28% of the stock, which recently reported a quarterly EPS of $0.91, surpassing estimates.
Darden Restaurants' CFO sold shares at an average price of $181.71, reducing their ownership by 41.33% to 10,262 shares valued at approximately $1.86 million. Insiders sold a total of 52,926 shares worth $9.85 million last quarter, with institutional investors holding 93.64% of the stock. Analysts have raised Darden's price targets, with a consensus rating of "Moderate Buy" and an average target of $201.36.
Raymond James Financial, Inc.
Companies
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
barclays lowers nCino price target to 24 while maintaining overweight rating
United States Dollar
Ncino Inc
Raymond James Financial, Inc.
Barclays PLC
USA
Sean Desmond
Alexander Sklar
Saket Kalia
Show more
11:22 02.04.2025
Roper Technologies announces dividend and insider stock transactions amid market activity
Truist Financial Corp
Robert W. Baird & Co. Inc.
Roper Technologies, Inc.
Raymond James Financial, Inc.
Procter & Gamble Co
JPMorgan Chase & Co.
USA
Brandon Rivera
Jason Conley
Show more
10:28 31.03.2025
barclays downgrades canada goose stock rating and lowers target price to eight dollars
Canadian Dollar
United States Dollar
Canada Goose Holdings Inc.
Raymond James Financial, Inc.
Barclays PLC
CAN
USA
Zachary Warring
Adrienne Yih
Show more
09:15 31.03.2025
raymond james receives mixed analyst ratings and price target adjustments
11:10 30.03.2025
bnp paribas and charles schwab increase stakes in healthequity stock
United States Dollar
BNP Paribas SA
Mizuho Medy Co.,Ltd.
The Goldman Sachs Group, Inc.
JMP Securities LLC
Wells Fargo & Company
Charles Schwab Investment Management Inc.
Raymond James Financial, Inc.
USA
Robert Selander
Show more
17:48 28.03.2025
ubs maintains buy rating on dollar tree with 95 target after family dollar sale
United States Dollar
Piper Sandler Cos
Raymond James Financial, Inc.
Dollar Tree, Inc.
USA
Michael Lasser
Show more
14:50 27.03.2025
Morgan Stanley rates Tenet Healthcare overweight with a target of 165 dollars
Cantor Fitzgerald Equity Opp A
Morgan Stanley
Truist Securities Inc.
Tenet Healthcare Corporation
Raymond James Financial, Inc.
Fitch Ratings Inc.
USA
Show more
08:43 26.03.2025
truist securities expands biotech research team with new analyst appointment
Piper Sandler Companies
Needham & Company LLC
RBC Capital Markets LLC
Morgan Stanley
Keybanc Capital Markets Inc.
Raymond James Financial, Inc.
Citigroup Inc.
USA
Mary Strother
Asthika Goonewardene
Srikripa Devarakonda
Nicole Germino
John McDonald
David Smith
David McCormick
Danielle Brill
Paul Durnan
Charles De Rozieres
Brian Foran
Rob Muir
Matt Coad
Show more
14:00 25.03.2025
analysts raise target prices for truist financial amid positive earnings report
Truist Financial Corporation
Amundi S.A.
Raymond James Financial, Inc.
State Street Corporation
KBC Group NV
Hightower Advisors LLC
USA
Show more
09:41 25.03.2025
darden restaurants insider trading and institutional investment updates
Darden Restaurants, Inc.
Benzinga
Wells Fargo & Company
KeyCorp
Robert W. Baird & Co. Inc.
Raymond James Financial, Inc.
USA
Rajesh Vennam
Todd Burrowes
Show more
20:33 22.03.2025
Trending
Subcategory
Corporate News
Stock Market Updates
Industry Trends
Industry Mergers & Acquisitions
Finance Mergers & Acquisitions
Banking Regulations
Global Financial Events
Domestic Politics
Retail and Consumer Goods
CEO Changes
Global Trade Developments
Startups & Entrepreneurship
Government Policies
Market Analysis and Predictions
Workplace Trends
Elections & Campaigns
Central Bank Actions
Government Economic Policies
Supply Chain Management
Hedge Funds & Private Equity
Countries:
Companies:
Tesla, Inc.
JPMorgan Chase & Co.
Apple Inc.
UniCredit S.p.A.
Banco BPM S.p.A.
Deutsche Bank Money Market PP
Barclays PLC
Credit Suisse Strategic Income I
CREDIT AGRICOLE
SpaceXCoin USD
Amazon.com, Inc.
Lloyds Banking Group plc
BNP Paribas SA
UBS Group AG
The Goldman Sachs Group, Inc.
Banco Santander, S.A.
Credit Agricole
Berkshire Hathaway Inc.
Reinsurance Group of America, Incorporated
Google Inc.
Currencies:
United States Dollar
Euro
Swiss Franc
British Pound Sterling
Chinese Yuan
Indian Rupee
Japanese Yen
South Korean Won
Offshore Chinese Yuan
Hong Kong Dollar
Singapore Dollar
Canadian Dollar
Vietnamese Đồng
Australian Dollar
Norwegian Krone
Filipino Peso
Mexican Peso
Indonesian Rupiah
Thai Baht
Danish Krone
People: